Evidence map›Paper›PMID 40704886›Full record

ArticleACS chemical biology2025

Segmental Isotope Labeling of the Prion Protein: Identification of a Key Residue for Copper-Mediated Interdomain Structure.

Francesca A Pavlovici, Kevin Singewald, Samuel Kaplan, Eefei Chen, Glenn L Millhauser

Abstract read
In one paragraph

Article in ACS chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Francesca A PavloviciDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, United States.ORCID 0000-0002-1611-5035
Kevin SingewaldDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, United States.ORCID 0000-0002-3041-5085
Samuel KaplanDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, United States.
Eefei ChenDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, United States.ORCID 0000-0001-7411-7779
Glenn L MillhauserDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, United States.ORCID 0000-0003-2442-7220

Funding

IRACDA at UCSC and CSUMBK12GM139185 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI FORSBERG, CAMILLA, HINCK, LINDSAY E · 2020 to 2024
$4.1M
Supplement Request for Emergency Replacement of EPR Amplifier and Acquisition of a Low Volume Resonator for Membrane ProteinsR35GM131781 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI GLENN L MILLHAUSER · 2019 to 2026
$3.6M
Upgrade of a Pulsed Electron Paramagnetic Resonance SpectrometerS10OD024980 · OD · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI MILLHAUSER, GLENN L · 2018 to 2018
$1.5M
NIGMS NIH HHS K12 GM139185NIGMS NIH HHS R35 GM131781NIH HHS S10 OD024980
6 · The paper itself

Abstract

The cellular prion protein is composed of two domains: a disordered N-terminal toxic effector domain and a three-helix C-terminal regulatory domain. Copper is thought to form a bridge between these two domains, inhibiting the protein's inherent neurotoxicity. However, the molecular details of how copper interacts with the C-terminal regulatory surface are unclear. To assess the potential role of conserved C-terminal His residues in copper coordination, we applied sortase-mediated ligation to create an expressed murine prion protein with segmental

Indexed as

CopperIsotope LabelingPrion ProteinsAminoacyltransferasesAnimalsElectron Spin Resonance SpectroscopyMiceModels, MolecularProtein DomainsAminoacyltransferasesCopperPrion Proteins

Identifiers

PMID40704886
PMCPMC12323768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.